Loading...
Back to narrative

NH: Future Performance Will Reflect Index Inclusion And Stable Margins With Balanced Outlook

Integrated Care And Oncology Expansion Will Shape India's Future

NH logo
NH
AnalystConsensusTarget
Not Invested
Published 30 Dec 2024

Update shared on 10 Dec 2025

Previous
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
45.2%
7D
-2.4%

Analysts have modestly raised their price target on Narayana Hrudayalaya to ₹2,042.64, citing sustained expectations for strong revenue growth, stable profit margins and a premium future valuation multiple.

What's in the News

  • A board meeting is scheduled on November 14, 2025 to review and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, and to consider other business matters (Company filing)
  • Narayana Hrudayalaya has been added to the FTSE All World Index (USD), increasing its visibility among global institutional investors (Index announcement)

Valuation Changes

  • Fair Value: Unchanged at ₹2,042.64, indicating no revision to the intrinsic valuation estimate.
  • Discount Rate: Stable at 12.76 percent, reflecting no change in the assumed cost of capital.
  • Revenue Growth: Effectively unchanged at about 33.9 percent, with only a negligible numerical adjustment in the model.
  • Net Profit Margin: Remains steady at about 11.2 percent, with only a minor technical refinement in the underlying assumption.
  • Future P/E: Held constant at roughly 37.0 times, implying no shift in the expected valuation multiple applied to earnings.

Have other thoughts on Narayana Hrudayalaya?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.